Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CABA

Cabaletta Bio, Inc.

Healthcare · USD

Set alert

Price alert · CABA

All alert types
1.51 USD -0.07 -4.73%
As of Oct 30, 2026 Extended hours 1.45 -3.97%
Bid
1.51 × 1
Ask
1.52 × 2
1.43 Day range 1.59
1.35 52-week range 4.15
YTD
-31.05%
1 year
-38.87%
Open
1.54
Prev close
1.59
Mkt cap
256.01M
Vol
3.76M
Avg vol
5.20M
EPS
-1.51
P/E
0.00
Div yield
0.00%
More statistics
Low
1.43
High
1.59
Forward P/E
-0.98
Beta
2.42
Short ratio
4.26
Inst. own
100.47%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
3.53
200-d avg
8.16
1y target
22.22

5D chart

Chart tools
Interval
1m5m15m30m
CABA five-day price chart1.321.401.481.551.63Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-1.41 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -1.3×
FY 2017: -962×FY 2018: -11.9×FY 2019: -3.4×FY 2020: -8.7×FY 2021: -2.1×FY 2022: -5.1×FY 2023: -13.8×FY 2024: -1.0×FY 2025: -1.3×
FY 2017 5y median -2.1× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 2.0×
FY 2017: -965×FY 2018: -13.6×FY 2019: 0.4×FY 2020: 2.6×FY 2021: 0.8×FY 2022: 2.6×FY 2023: 3.9×FY 2024: 0.7×FY 2025: 2.0×
FY 2017 5y median 2.0× FY 2025
P/FCF -1.7×
FY 2017: 0.0×FY 2018: -31.1×FY 2019: -3.5×FY 2020: -10.5×FY 2021: -2.8×FY 2022: -5.6×FY 2023: -17.1×FY 2024: -1.2×FY 2025: -1.7×
FY 2017 5y median -2.8× FY 2025
EV/EBITDA -1.0×
FY 2017: 2884×FY 2018: -26.0×FY 2019: 4.2×FY 2020: -5.7×FY 2021: 0.5×FY 2022: -3.8×FY 2023: -11.2×FY 2024: 0.3×FY 2025: -1.0×
FY 2017 5y median -1.0× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -59.1%
FY 2017: 0.0%FY 2018: -3.2%FY 2019: -28.8%FY 2020: -9.5%FY 2021: -36.2%FY 2022: -18.0%FY 2023: -5.8%FY 2024: -80.5%FY 2025: -59.1%
FY 2017 5y median -36.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -149.8%
FY 2017: 100.4%FY 2018: 114.1%FY 2019: -12.2%FY 2020: -30.4%FY 2021: -39.2%FY 2022: -50.7%FY 2023: -28.7%FY 2024: -76.1%FY 2025: -149.8%
FY 2017 5y median -50.7% FY 2025
ROIC -123.8%
FY 2017: 100.4%FY 2018: -18.6%FY 2019: -13.5%FY 2020: -30.9%FY 2021: -39.3%FY 2022: -49.4%FY 2023: -31.0%FY 2024: -72.8%FY 2025: -123.8%
FY 2017 5y median -49.4% FY 2025
ROA -101.7%
FY 2017: -25000.0%FY 2018: -35.7%FY 2019: -12.0%FY 2020: -29.1%FY 2021: -36.6%FY 2022: -45.3%FY 2023: -26.7%FY 2024: -62.6%FY 2025: -101.7%
FY 2017 5y median -45.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -37.6%
FY 2017: 0.0%FY 2018: -2377.2%FY 2019: -201.7%FY 2020: -81.1%FY 2021: -36.9%FY 2022: -16.9%FY 2023: -37.9%FY 2024: -67.6%FY 2025: -37.6%
FY 2017 FY 2025
EPS (diluted) 29.9%
FY 2017: 0.0%FY 2018: -7976.9%FY 2019: -384.5%FY 2020: 64.6%FY 2021: -25.0%FY 2022: -0.6%FY 2023: 8.8%FY 2024: -41.8%FY 2025: 29.9%
FY 2017 FY 2025
Free Cash Flow -46.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -259.1%FY 2020: -63.7%FY 2021: -28.7%FY 2022: -38.4%FY 2023: -11.1%FY 2024: -66.7%FY 2025: -46.3%
FY 2017 FY 2025

Financial Health

Current Ratio 2.8×
FY 2017: 0.0×FY 2018: 36.0×FY 2019: 44.7×FY 2020: 21.9×FY 2021: 14.9×FY 2022: 11.5×FY 2023: 15.3×FY 2024: 6.2×FY 2025: 2.8×
FY 2017 5y median 11.5× FY 2025
Quick Ratio 2.8×
FY 2017: 0.0×FY 2018: 36.0×FY 2019: 44.7×FY 2020: 21.9×FY 2021: 14.9×FY 2022: 11.5×FY 2023: 15.3×FY 2024: 6.2×FY 2025: 2.8×
FY 2017 5y median 11.5× FY 2025
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: -4.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: -0.0×FY 2018: -1.8×FY 2019: 7.3×FY 2020: 3.1×FY 2021: 2.7×FY 2022: 1.5×FY 2023: 2.8×FY 2024: 1.3×FY 2025: 0.3×
FY 2017 5y median 1.5× FY 2025
Interest Coverage -85.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -167×FY 2025: -85.9×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 17.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -59.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31